Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy
- 24 August 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8765), 483-487
- https://doi.org/10.1016/0140-6736(91)90554-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.Journal of Clinical Oncology, 1989
- Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.Journal of Clinical Oncology, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.BMJ, 1987
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.BMJ, 1979